COMPOSITIONS, METHODS OF MAKING A COMPOSITION, AND METHODS OF USE

BACKGROUND

The globalization of business, travel and communication brings increased attention to worldwide exchanges between communities and countries, including the potential globalization of the bacterial and pathogenic ecosystem. Bactericides and fungicides have been developed to control diseases in man, animal and plants, and must evolve to remain effective as more and more antibiotic, pesticide and insecticide resistant bacteria and fungi appear around the globe.

Bacterial resistance to antimicrobial agents has also emerged, throughout the world, as one of the major threats to both man and the agrarian lifestyle. Resistance to antibacterial and antifungal agents has emerged as an agricultural issue that requires attention and 20 improvements in the treatment materials in use today.

For example, focusing on plants, there are over 300,000 diseases that afflict plants worldwide, resulting in billions of dollars of annual crop losses. The antibacterial/antifungal formulations in existence today could be improved and made more effective.

SUMMARY

Embodiments of the present disclosure, in one aspect, relate to compositions including a copper/silica nanocomposite and a polymer, methods of making a composition, methods of using a composition, and the like.

An embodiment of the present disclosure provides for a composition, among others, that includes: a copper/silica nanocomposite having a silica gel matrix that includes copper from one or more of copper nanoparticles and copper ions, and a polymer selected from the group consisting of: polyvinylpyrrolidone, polyacrylamide, polylactic acid, polyglycolic acid, starch, chitosan, a quaternary ammonium compound, and a combination thereof.

An embodiment of the present disclosure provides for a method of making a composition, among others, that includes: mixing a silica precursor compound, a copper precursor compound, and water; adjusting the pH to less than about 7 and holding for about 12 to 36 hours; forming a copper/silica nanocomposite having a silica gel matrix that includes copper from one or more of copper nanoparticles and copper ions; mixing a polymer with the mixture while having an acidic pH for about 12 to 36 hours, wherein the polymer is selected from the group consisting of: a polymer selected from the group consisting of: polyvinylpyrrolidone, polyacrylamide, polylactic acid, polyglycolic acid, starch, chitosan, a quaternary ammonium compound, and a combination thereof; raising the pH to about 4 to 10; and forming the composition.

An embodiment of the present disclosure provides for a method, among others, that includes: disposing a composition on a surface, wherein the composition has a copper/silica nanocomposite having a silica gel matrix that includes copper from one or more of copper nanoparticles and copper ions, and a polymer selected from the group consisting of: a polymer selected from the group consisting of: polyvinylpyrrolidone, polyacrylamide, polylactic acid, polyglycolic acid, starch, chitosan, a quaternary ammonium compound, and a combination thereof; and killing a substantial portion of a microorganism or inhibiting or substantially inhibiting the growth of the microorganisms on the surface of a structure or that come into contact with the surface of the structure.

Other composition, methods, features, and advantages will be, or become, apparent to one with skill in the art upon examination of the following drawings and detailed description. It is intended that all such additional structures, systems, methods, features, and advantages be included within this description, be within the scope of the present disclosure, and be protected by the accompanying claims.

BRIEF DESCRIPTION OF THE DRAWINGS

Many aspects of this disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present disclosure. Moreover, in the drawings, like reference numerals designate corresponding parts throughout the several views.

FIG. 1 illustrates spherical clusters of material within SG0023 seen in SEM.

FIG. 2 illustrates EDS of elements in sample from FIG. 1 within SG0023. Cu and Si confirmed.

FIG. 3 illustrates spherical clusters of material within SG0023 seen in SEM.

FIG. 4 illustrates EDS of elements in sample from FIG. 3 within SG0023. Cu and Si confirmed.

FIG. 5 illustrates spherical clusters of material within SG0023 seen in SEM.

FIG. 6 illustrates EDS of SG0023 sample seen in HRTEM. Cu and Si confirmed.

FIG. 7 illustrates high-resolution, low magnification image of SG0023 showing areas of dark contrast indicating electron rich material.

FIG. 8 illustrates SAED image of SG0023 confirming crystalline nature.

FIG. 9 illustrates high-resolution, high magnification image of SG0023 showing areas of dark contrast indicating electron rich material.

FIG. 10 illustrates high-resolution, high magnification image of SG0023 showing areas of dark contrast indicating electron rich material. Cu crystallites can be seen with sizes between 4-8 nm. Lattice spacing of crystallites determined as 2.76 Å, 2.27 Å, 3.03 Å, 1.78 Å and 2.54 Å.

FIG. 11 illustrates high-resolution, high magnification image of SG0023 showing areas of dark contrast indicating electron rich material. Cu Crystallites can be seen with sizes between 4-8 nm. Lattice spacing of crystallites determined as 2.76 Å, 2.27 Å, 3.03 Å, 1.78 Å and 2.54 Å.

FIG. 12 illustrates EDS of SG0024 sample seen in HRTEM. Cu and Si confirmed.

FIG. 13 illustrates high-resolution, low magnification image of SG0024 showing areas of dark contrast indicating electron rich material.

FIG. 14 illustrates high-resolution, low magnification image of SG0024 showing areas of dark contrast indicating electron rich material.

FIG. 15 illustrates SAED image of SG0024 confirming crystalline nature.

FIG. 16 illustrates high-resolution, high magnification image of SG0024 showing areas of dark contrast indicating electron rich material. Cu Crystallites can be seen with sizes between 4-8 nm. Lattice spacing of crystallites determined as 2.75 Å, 2.45 Å and 2.26 Å.

FIG. 17 illustrates high-resolution, high magnification image of SG0024 showing areas of dark contrast indicating electron rich material. Cu crystallites can be seen with sizes between 4-8 nm. Lattice spacing of crystallites determined as 2.75 Å, 2.45 Å and 2.26 Å.

FIG. 18 illustrates spherical clusters of material within SG0024 seen in SEM.

FIG. 19 illustrates EDS of elements in sample from FIG. 18 within SG0024. Cu and Si confirmed.

FIG. 20 illustrates clusters of material within SG0024 seen in SEM.

FIG. 21 illustrates EDS of elements in sample from FIG. 20 within SG0024. Cu and Si confirmed.

FIG. 22 is a table that illustrates the phytotoxicity studies of SG0001, SG0005, SG0015, SG0017 and SG0018 at Cu concentrations of 450, 700 and 900 ppm. (−) No damage, (+) Moderate damage, (++) Heavy damage.

FIG. 23 is a table that illustrates the phytotoxicity studies of SG0020, SG0021 and SG0022 at Cu concentrations of 300, 500 and 700 ppm. (−) No damage, (+) Moderate damage, (++) Heavy damage.

FIG. 24 is a table that illustrates the phytotoxicity studies of SG0022M, SG0023 and SG0024 at Cu concentrations of 500, 700 and 900 ppm. (−) No damage, (+) Moderate damage, (++) Heavy damage.

FIG. 25 is a study that illustrates the minimum inhibitory concentration (MIC) of SG nanoformulations and Kocide 3000 against E. coli expressed in Cu concentration ((μg/mL).

FIG. 26 is a graphs that illustrates the growth inhibition of E. coli in the presence of SG0001, SG0005, SG0015, SG0017, SG0018 and Kocide 3000.

FIG. 27 is a graph that illustrates the growth inhibition of E. coli in the presence of SG0020, SG0021, SG0022 and Kocide 3000.

FIG. 28 is a graph that illustrates the growth inhibition of E. coli in the presence of SG0022M, SG0023, SG0024 and Kocide 3000.

FIG. 29 illustrates EDS of SG0025 sample seen in HRTEM. Cu and Si confirmed.

FIG. 30 illustrates high-resolution, low magnification image of SG0025 showing areas of dark contrast indicating electron rich material.

FIG. 31 illustrates high-resolution, high magnification image of SG0025 showing areas of dark contrast indicating electron rich material. Cu Crystallites can be seen with sizes between 4-8 nm. Lattice spacing of crystallites determined as 2.48 Å, 2.48 Å, 1.44 Å and 1.87 Å which corresponds to Cu₂O, metallic Cu, Cu(OH)₂and CuO respectively.

FIG. 32 illustrates SAED image of SG0025 confirming crystalline nature.

FIG. 33 illustrates EDS of SG0026 sample seen in HRTEM. Cu and Si confirmed.

FIG. 34 illustrates high-resolution, low magnification image of SG0026 showing areas of dark contrast indicating electron rich material.

FIG. 35 illustrates high-resolution, high magnification image of SG0026 showing areas of dark contrast indicating electron rich material. Cu Crystallites can be seen with sizes between 4-8 nm. Lattice spacing of crystallites determined as 2.48 Å, 2.11 Å, 1.44 Å, 1.95 Å, 2.79 Å and 1.87 Å which corresponds to Cu₂O, metallic Cu, Cu(OH)₂and CuO respectively.

FIG. 36 illustrates SAED image of SG0026 confirming crystalline nature.

FIG. 37 is a table that illustrates the phytotoxicity studies of SG0025 and SG0026 at Cu concentrations of 500 and 900 ppm. (−) No damage, (+) Moderate damage, (++) Heavy damage.

FIG. 38 is a table that illustrates the phytotoxicity studies of SG0025 and SG0026 at Cu concentrations of 900 ppm. Exhibiting no damage from SG0025 and SG0026. Damage seen in CuSO₄control.

FIG. 39 is a graph that illustrates the growth inhibition of E. coli in the presence of SG0025, SG0026 and Kocide 3000 at metallic Cu 400 μg/mL.

DETAILED DESCRIPTION

Before the present disclosure is described in greater detail, it is to be understood that this disclosure is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described.

All publications and patents cited in this specification are herein incorporated by reference as if each individual publication or patent were specifically and individually indicated to be incorporated by reference and are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited. The citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided could be different from the actual publication dates that may need to be independently confirmed.

As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features that may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure. Any recited method can be carried out in the order of events recited or in any other order that is logically possible.

Embodiments of the present disclosure will employ, unless otherwise indicated, techniques of chemistry, polymer chemistry, biology, and the like, which are within the skill of the art. Such techniques are explained fully in the literature.

The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how to perform the methods and use the compositions and compounds disclosed and claimed herein. Efforts have been made to ensure accuracy with respect to numbers (e.g., amounts, temperature, etc.), but some errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, temperature is in ° C., and pressure is in atmospheres. Standard temperature and pressure are defined as 25° C. and 1 atmosphere.

Before the embodiments of the present disclosure are described in detail, it is to be understood that, unless otherwise indicated, the present disclosure is not limited to particular materials, reagents, reaction materials, manufacturing processes, or the like, as such can vary. It is also to be understood that the terminology used herein is for purposes of describing particular embodiments only, and is not intended to be limiting. It is also possible in the present disclosure that steps can be executed in different sequence where this is logically possible.

It must be noted that, as used in the specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a support” includes a plurality of supports. In this specification and in the claims that follow, reference will be made to a number of terms that shall be defined to have the following meanings unless a contrary intention is apparent.

Definitions

The term “antimicrobial characteristic” refers to the ability to kill and/or inhibit the growth of microorganisms. A substance having an antimicrobial characteristic may be harmful to microorganisms (e.g., bacteria, fungi, protozoans, algae, and the like). A substance having an antimicrobial characteristic can kill the microorganism and/or prevent or substantially prevent the growth or reproduction of the microorganism.

The term “antibacterial characteristic” refers to the ability to kill and/or inhibit the growth of bacteria. A substance having an antibacterial characteristic may be harmful to bacteria. A substance having an antibacterial characteristic can kill the bacteria and/or prevent or substantially prevent the replication or reproduction of the bacteria.

“Uniform plant surface coverage” refers to a uniform and complete (e.g., about 100%) wet surface due to spray application of embodiments of the present disclosure. In other words, spray application causes embodiments of the present disclosure to spread throughout the plant surface.

“Substantial uniform plant surface coverage” refers to about 70%, about 80%, about 90%, or more uniform plant surface coverage.

“Substantially covering” refers to covering about 70%, about 80%, about 90%, or more, of the leaves and branches of a plant.

“Plant” refers to trees, plants, shrubs, flowers, and the like as well as portions of the plant such as twigs, leaves, stems, branches, fruit, flowers, and the like. In a particular embodiment, the term plant includes a fruit tree such as a citrus tree (e.g., orange tree, lemon tree, lime tree, and the like).

The terms “alk” or “alkyl” refer to straight or branched chain hydrocarbon groups having 1 to 12 carbon atoms, preferably 1 to 8 carbon atoms, such as methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, pentyl, hexyl, heptyl, n-octyl, dodecyl, octadecyl, amyl, 2-ethylhexyl, and the like. Alkyl can include alkyl, dialkyl, trialkyl, and the like.

As used herein, “treat”, “treatment”, “treating”, and the like refer to acting upon a disease or condition with a composition of the present disclosure to affect the disease or condition by improving or altering it. In addition, “treatment” includes completely or partially preventing (e.g., about 70% or more, about 80% or more, about 90% or more, about 95% or more, or about 99% or more) a plant form acquiring a disease or condition. The phrase “prevent” can be used instead of treatment for this meaning. “Treatment,” as used herein, covers one or more treatments of a disease in a plant, and includes: (a) reducing the risk of occurrence of the disease in a plant predisposed to the disease but not yet diagnosed as infected with the disease (b) impeding the development of the disease, and/or (c) relieving the disease, e.g., causing regression of the disease and/or relieving one or more disease symptoms.

The terms “bacteria” or “bacterium” include, but are not limited to, Gram positive and Gram negative bacteria. Bacteria can include, but are not limited to, Abiotrophia, Achromobacter, Acidaminococcus, Acidovorax, Acinetobacter, Actinobacillus, Actinobaculum, Actinomadura, Actinomyces, Aerococcus, Aeromonas, Afipia, Agrobacterium, Alcaligenes, Alloiococcus, Alteromonas, Amycolata, Amycolatopsis, Anaerobospirillum, Anabaena affinis and other cyanobacteria (including the Anabaena, Anabaenopsis, Aphanizomenon, Camesiphon, Cylindrospermopsis, Gloeobacter Hapalosiphon, Lyngbya, Microcystis, Nodularia, Nostoc, Phormidium, Planktothrix, Pseudoanabaena, Schizothrix, Spirulina, Trichodesmium, and Umezakia genera) Anaerorhabdus, Arachnia, Arcanobacterium, Arcobacter, Arthrobacter, Atopobium, Aureobacterium, Bacteroides, Balneatrix, Bartonella, Bergeyella, Bifidobacterium, Bilophila Branhamella, Borrelia, Bordetella, Brachyspira, Brevibacillus, Brevibacterium, Brevundimonas, Brucella, Burkholderia, Buttiauxella, Butyrivibrio, Calymmatobacterium, Campylobacter, Capnocytophaga, Cardiobacterium, Catonella, Cedecea, Cellulomonas, Centipeda, Chlamydia, Chlamydophila, Chromobacterium, Chyseobacterium, Chryseomonas, Citrobacter, Clostridium, Collinsella, Comamonas, Corynebacterium, Coxiella, Cryptobacterium, Delftia, Dermabacter, Dermatophilus, Desulfomonas, Desulfovibrio, Dialister, Dichelobacter, Dolosicoccus, Dolosigranulum, Edwardsiella, Eggerthella, Ehrlichia, Eikenella, Empedobacter, Enterobacter, Enterococcus, Erwinia, Erysipelothrix, Escherichia, Eubacterium, Ewingella, Exiguobacterium, Facklamia, Filifactor, Flavimonas, Flavobacterium, Francisella, Fusobacterium, Gardnerella, Gemella, Globicatella, Gordona, Haemophilus, Hafnia, Helicobacter, Helococcus, Holdemania Ignavigranum, Johnsonella, Kingella, Klebsiella, Kocuria, Koserella, Kurthia, Kytococcus, Lactobacillus, Lactococcus, Lautropia, Leclercia, Legionella, Leminorella, Leptospira, Leptotrichia, Leuconostoc, Listeria, Listonella, Megasphaera, Methylobacterium, Microbacterium, Micrococcus, Mitsuokella, Mobiluncus, Moellerella, Moraxella, Morganella, Mycobacterium, Mycoplasma, Myroides, Neisseria, Nocardia, Nocardiopsis, Ochrobactrum, Oeskovia, Oligella, Orientia, Paenibacillus, Pantoea, Parachlamydia, Pasteurella, Pediococcus, Peptococcus, Peptostreptococcus, Photobacterium, Photorhabdus, Phytoplasma, Plesiomonas, Porphyrimonas, Prevotella, Propionibacterium, Proteus, Providencia, Pseudomonas, Pseudonocardia, Pseudoramibacter, Psychrobacter, Rahnella, Ralstonia, Rhodococcus, Rickettsia Rochalimaea Roseomonas, Rothia, Ruminococcus, Salmonella, Selenomonas, Serpulina, Serratia, Shewenella, Shigella, Simkania, Slackia, Sphingobacterium, Sphingomonas, Spirillum, Spiroplasma, Staphylococcus, Stenotrophomonas, Stomatococcus, Streptobacillus, Streptococcus, Streptomyces, Succinivibrio, Sutterella, Suttonella, Tatumella, Tissierella, Trabulsiella, Treponema, Tropheryma, Tsakamurella, Turicella, Ureaplasma, Vagococcus, Veillonella, Vibrio, Weeksella, Wolinella, Xanthomonas, Xenorhabdus, Yersinia, and Yokenella. Other examples of bacterium include Mycobacterium tuberculosis, M. bovis, M. typhimurium, M. bovis strain BCG, BCG subs trains, M. avium, M. intracellulare, M. africanum, M. kansasii, M. marinum, M. ulcerans, M. avium subspecies paratuberculosis, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus equi, Streptococcus pyogenes, Streptococcus agalactiae, Listeria monocytogenes, Listeria ivanovii, Bacillus anthraces, B. subtilis, Nocardia asteroides, and other Nocardia species, Streptococcus viridans group, Peptococcus species, Peptostreptococcus species, Actinomyces israelii and other Actinomyces species, and Propionibacterium acnes, Clostridium tetani, Clostridium botulinum, other Clostridium species, Pseudomonas aeruginosa, other Pseudomonas species, Campylobacter species, Vibrio cholera, Ehrlichia species, Actinobacillus pleuropneumoniae, Pasteurella haemolytica, Pasteurella multocida, other Pasteurella species, Legionella pneumophila, other Legionella species, Salmonella typhi, other Salmonella species, Shigella species Brucella abortus, other Brucella species, Chlamydi trachomatis, Chlamydia psittaci, Coxiella burnetti, Escherichia coli, Neiserria meningitidis, Neiserria gonorrhea, Haemophilus influenzae, Haemophilus ducreyi, other Hemophilus species, Yersinia pestis, Yersinia enterolitica, other Yersinia species, Escherichia coli, E. hirae and other Escherichia species, as well as other Enterobacteria, Brucella abortus and other Brucella species, Burkholderia cepacia, Burkholderia pseudomallei, Francisella tularensis, Bacteroides fragilis, Fudobascterium nucleatum, Provetella species, and Cowdria ruminantium, or any strain or variant thereof. The Gram-positive bacteria may include, but is not limited to, Gram positive Cocci (e.g., Streptococcus, Staphylococcus, and Enterococcus). The Gram-negative bacteria may include, but is not limited to, Gram negative rods (e.g., Bacteroidaceae, Enterobacteriaceae, Vibrionaceae, Pasteurellae and Pseudomonadaceae). In an embodiment, the bacteria can include Mycoplasma pneumoniae.

The term “protozoan” as used herein includes, without limitations flagellates (e.g., Giardia lamblia), amoeboids (e.g., Entamoeba histolitica), and sporozoans (e.g., Plasmodium knowlesi) as well as ciliates (e.g., B. coli). Protozoan can include, but it is not limited to, Entamoeba coli, Entamoeabe histolitica, Iodoamoeba buetschlii, Chilomastix meslini, Trichomonas vaginalis, Pentatrichomonas homini, Plasmodium vivax, Leishmania braziliensis, Trypanosoma cruzi, Trypanosoma brucei, and Myxoporidia.

The term “algae” as used herein includes, without limitations microalgae and filamentous algae such as Anacystis nidulans, Scenedesmus sp., Chlamydomonas sp., Clorella sp., Dunaliella sp., Euglena sp., Prymnesium sp., Porphyridium sp., Synechoccus sp., Botryococcus braunii, Crypthecodinium cohnii, Cylindrotheca sp., Microcystis sp., Isochrysis sp., Monallanthus satina, M. minutum, Nannochloris sp., Nannochioropsis sp., Neochloris oleoabundans, Nitzschia sp., Phaeodactylum tricornutum, Schizochytrium sp., Senedesmus obliquus, and Tetraselmis sueica as well as algae belonging to any of Spirogyra, Cladophora, Vaucheria, Pithophora and Enteromorpha genera.

The term “fungi” as used herein includes, without limitations, a plurality of organisms such as molds, mildews and rusts and include species in the Penicillium, Aspergillus, Acremonium, Cladosporium, Fusarium, Mucor, Nerospora, Rhizopus, Tricophyton, Botryotinia, Phytophthora, Ophiostoma, Magnaporthe, Stachybotrys and Uredinalis genera.

Discussion:

In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to compositions including a copper/silica nanocomposite and a polymer, methods of making a composition, methods of using a composition, and the like. In an embodiment, the composition can be used as an antimicrobial agent to kill and/or inhibit the formation of microorganisms on a surface such as a tree, plant, and the like. An advantage of the present disclosure is that the composition is water soluble, non-phytotoxic, film-forming, and has antimicrobial properties. In particular, the combination of the copper/silica nanocomposite and a polymer in the composition provides for water soluble formulation that can form a film on a surface with enhanced adherence as compared to other compositions not including the polymer, while not degrading the antimicrobial properties of the copper/silica nanocomposite.

In addition, embodiments of the present disclosure provide for a composition that can be used for multiple purposes. Embodiments of the present disclosure are advantageous in that they can slowly release one or more agents that can be used to prevent, substantially prevent and/or treat or substantially treat a disease or condition in a plant, act as an antibacterial and/or antifungal. Another advantage of an embodiment of the present disclosure is that the agent(s) can be controllably released over a long period of time (e.g., from the day of application until a few weeks or months (e.g., about 6 or 8 months)). Another advantage of the present disclosure is that the composition is substantially (e.g., greater than about 95% and about 99%) or completely transparent to visible light or translucent to visible light.

In an embodiment, the composition may have an antimicrobial characteristic (e.g., kills at least 70%, at least 80%, at least 90%, at least 95%, or at least 99% of the microorganisms (e.g., bacteria) on the surface and/or reduces the amount of microorganisms that form or grow on the surface by at least 70%, at least 80%, at least 90%, at least 95%, or at least 99%, as compared to a similar surface without the composition disposed on the surface). Additional details are described in the Examples.

In an embodiment, the composition can be disposed on a surface of a structure. In an embodiment, the structure can include plants such as trees, shrubs, grass, agricultural crops, and the like, includes leaves and fruit. In an embodiment, the composition provides uniform plant surface coverage, substantial uniform plant surface coverage, or substantially covers the plant. In an embodiment, the composition can be used to treat a plant having a disease or to prevent the plant from obtaining a disease.

In an embodiment, the structure can include those that may be exposed to microorganisms and/or that microorganisms can grow on, such as, without limitation, fabrics, cooking counters, food processing facilities, kitchen utensils, food packaging, swimming pools, metals, drug vials, medical instruments, medical implants, yarns, fibers, gloves, furniture, plastic devices, toys, diapers, leather, tiles, and flooring materials. In an embodiment, the structure can include textile articles, fibers, filters or filtration units (e.g., HEPA for air and water), packaging materials (e.g., food, meat, poultry, and the like food packaging materials), plastic structures (e.g., made of a polymer or a polymer blend), glass or glass like structures on the surface of the structure, metals, metal alloys, or metal oxides structure, a structure (e.g., tile, stone, ceramic, marble, granite, or the like), and a combination thereof.

In an embodiment, the copper component can include a copper ion, metallic copper, copper oxide, copper oxychloride, copper sulfate, copper hydroxide, and a combination thereof. The copper component can include copper ions that are electrostatically bound to the silica nanoparticle core or to the amorphous silica matrix (e.g., not directly to the particles), copper covalently bound to the hydrated surface of the nanoparticle or to the amorphous silica matrix, and/or copper oxides and/or hydroxides bound to the surface of the nanoparticle or amorphous silica matrix. In an embodiment, the composition includes the copper component in two or in all three of these states.

In an embodiment, the copper components can be in a soluble (amorphous) and/or an insoluble (crystalline) form. By controlling the soluble and insoluble ratio, the release rate of the copper component can be controlled as a function of time. As a result, the release rate of the copper component can be controlled so that antibacterial and/or antifungal characteristics can be effective for time frames of days to weeks or to months. In other words, the copper component can be released from the multifunctional silica based nanoparticle or gel starting from the day of application and continuing release to about a week, about a month, about two months, about three months, about four months, about five months, about six months, about seven month, or about eight months. The ratio of the soluble to insoluble copper component can be adjusted to control the release rate. In an embodiment, the ratio of the soluble copper to the insoluble copper (e.g., Chelated Cu)_X(Crystalline Cu)_1-X) can be out 0:1 to 1:0 (X can be about 0.1 to 0.99 or about 0.01 to 1), and can be modified in increments of about 0.01 to produce the ratio that releases the Cu for the desired period of time. Parameters that can be used to adjust the ratio include: solvent polarity and protic nature (i.e., hydrogen bonding capability), Cu nanoparticle precursor (e.g., Cu sulfate) concentration, temperature, concentration of silane precursor (such as tetraethylorthosilicate, TEOS), amount of polymer, type of polymer, and the like. In an embodiment, the copper nanoparticle precursor compound can be insoluble Cu compounds (e.g., copper hydroxide, cupric chloride, cuprous chloride, cupric oxide, cuprous oxide), soluble Cu compounds (e.g., copper sulfate, copper nitrate), or a combination thereof. In an embodiment, the silane nanoparticle precursor can be alkyl (C2 to C6) silane, tetraethoxysilane (TEOS), tetramethoxysilane (TMOS), sodium silicate, a silane precursor that can produce silicic acid or silicic acid like intermediates, or a combination thereof.

In an embodiment, the metallic copper can be about 1 microgram (μg)/mL to 20 milligram (mg)/mL weight percent, of the copper/silica-polymer nanocomposite.

“Silica gel matrix” or “silica nanogel matix” refers to amorphous gel like substance that is formed by the interconnection of silica particles (e.g., nanoparticles (e.g., 2 to 500 nm or 5 to 50 nm)) to one another. In an embodiment, the amorphous silica gel has no ordered (e.g., defined) structure (opposite to crystalline structure) so an “amorphous gel” refers to gel material having amorphous structural composition. In an embodiment, the silica nanoparticles of the silica gel are interconnected covalently (e.g., through —Si—O—Si— bonds), physically associated via Van der Waal forces, and/or through ionic interactions (e.g., with copper ions).

In an embodiment, the silica particles are interconnected and copper nanoparticles can be disposed within the silica gel matrix and/or attached to one or more silica particles. In an embodiment, the copper nanoparticles are substantially (e.g., greater than about 80%, about 90%, about 95%, or about 99%) monodisperse. In an embodiment, the silica gel is disposed around the entire copper nanoparticle, which, although not intending to be bound by theory, causes the copper/silica nanocomposite to be transparent to visible light. Embodiments of the present disclosure include the appropriate ratio of silica gel to copper nanoparticle so that the nanocomposite is transparent to visible light, while also maintaining antimicrobial characteristics.

In an embodiment, the diameter of the particles (e.g., silica and/or copper) can be varied from a few nanometers to hundreds of nanometers by appropriately adjusting synthesis parameters, such as amounts of silane precursor, polarity of reaction medium, pH, time or reaction, and the like. For example, the diameter of the particles can be controlled by adjusting the time frame of the reaction. In an embodiment, the silica and copper nanoparticles can independently be about 2 to 25 nm or about 5 to 20 nm. In addition, the concentration of the copper ions can be appropriately adjusting synthesis parameters, such as amounts of silane precursor, polarity of reaction medium, pH, time or reaction, and the like.

As mentioned above, the composition also includes a polymer. Although not intending to be bound by theory, the polymer or polymer copper/silica nanocomposite may increase the solubility of the composition, enhance the film-forming characteristic of the composition, and/or enhance the adherence characteristics of the composition, while not retarding the antimicrobial characteristics of the composition. In an embodiment, the polymer can include one or more of the following: polyacrylamide, polyvinyl alcohol, polyvinyl pyrolidone, polyethyleneimine, polyethylene glycol, polypropylene gycol, polyacrylic acid, dextran, chitosan (e.g., water soluble), alginate, polyvinylpyrrolidone, polyacrylamide, polylactic acid, polyglycolic acid, starch, and a combination thereof (e.g., poly(lactic-co-glycolic acid) (PLGA)). In an embodiment, the ratio of copper/silica nanocomposite to polymer is about 0.1:1 to 3:1 or about 0.5:1 to 2:1. The polymer was added to Cu/Silica nanogel after acid mediated TEOS hydrolysis in acidic conditions. The pH was then raised to about 8 to 9. Based on HRTEM results, the Cu/Silica nanogel integrity remained intact after polymer addition. Therefore, the polymer stabilized Cu/silica nanogel material at higher pHs (e.g., about 6 to 9) by surface interacting with Cu/silica nanogel via intermolecular forces.

In addition, the polymer can include quaternary ammonium compounds such as those described below:

CAS No.
Quaternary ammonium compound

61789-18-2
Coco alkyltrimethyl quaternary ammonium chlorides

61790-41-8
Quaternary ammonium compounds, trimethylsoya alkyl, chlorides

61791-10-4
Quaternary ammonium compounds, coco alkylbis(hydroxyethyl)methyl, ethoxylated,

chlorides (Data Submitter Rights)

64755-05-1
Quaternary ammonium compounds, bis(hydroxyethyl)methyltallow alkyl, ethoxylated,

chlorides (Data Submitter Rights)

67784-77-4
Quaternary ammonium compounds, bis(hydroxyethyl)methyltallow alkyl, chlorides

(Data Submitter Rights)

68187-69-9
Quaternary ammonium compounds, (hydrogenated tallow

alkyl)bis(hydroxyethyl)methyl, ethoxylated, chlorides (Data Submitter Rights)

70750-47-9
Quaternary ammonium compounds, coco alkylbis(hydroxyethyl)methyl chloride (Data

Submitter Rights)

8030-78-2
Tallow trimethyl ammonium chloride

61788-92-9
Quaternary ammonium compounds, dimethyldisoya alkyl, chlorides

68424-85-1
Alkyl* dimethyl benzyl ammonium chloride *(50% C14, 40% C12, 10% C16)

68918-78-5
Quaternary ammonium compounds, bis(C8-18 and C18-unsatd. alkyl)dimethyl,

chlorides

68956-79-6
Alkylbenzyldimethylammonium chlorides, C12-18-alkyl [(ethylphenyl)methyl]

dimethyl

Furthermore, other polymers can include EPA approved polymers such as in Table A below (Title 40: Protection of the Environment, § 180.960 Polymers).

Polymer
CAS No.

Acetic acid ethenyl ester, polymer with ethenol and (α)-2-propenyl-
137091-12-4

(ω)-hydroxypoly (oxy-1,2-ethanediyl) minimum number average

molecular weight (in amu), 15,000

Acetic acid ethenyl ester, polymer with 1-ethenyl-2-pyrrolidinone
25086-89-9

Acetic acid ethenyl ester, polymer with oxirane, minimum number
25820-49-9

average molecular weight (in amu), 17,000

Acetic acid ethenyl ester, polymer with sodium 2-methyl-2-[(1-oxo-2-
924892-37-5

propen-1-yl)amino]-1-propanesulfonate (1:1), hydrolyzed, minimum

number average molecular weight (in amu), 61,000

Acrylic acid-benzyl methacrylate-1-propanesulfonic acid, 2-methyl-2-
1152297-42-1

[(1-oxo-2-propenyl)amino]-, monosodium salt, minimum number

average molecular weight (in amu), 1500

Acrylic acid, polymerized, and its ethyl and methyl esters
None

Acrylic acid-sodium acrylate-sodium-2-methylpropanesulfonate
97953-25-8

copolymer, minimum average molecular weight (in amu), 4,500

Acrylic acid-stearyl methacrylate copolymer, minimum number
27756-15-6

average molecular weight (in amu), 2,500

Acrylic acid, styrene, α-methyl styrene copolymer, ammonium salt,
89678-90-0

minimum number average molecular weight (in amu), 1,250

Acrylic acid terpolymer, partial sodium salt, minimum number
151006-66-5

average molecular weight (in amu), 2,400

Acrylic polymers composed of one or more of the following
None

monomers: Acrylic acid, methyl acrylate, ethyl acrylate, butyl

acrylate, hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxybutyl

acrylate, carboxyethyl acrylate, methacrylic acid, methyl

methacrylate, ethyl methacrylate, butyl methacrylate, isobutyl

methacrylate, hydroxyethyl methacrylate, hydroxypropyl

methacrylate, hydroxybutyl methacrylate, lauryl methacrylate, and

stearyl methacrylate; with none and/or one or more of the following

monomers: Acrylamide, N-methyl acrylamide, N,N-dimethyl

acrylamide, N-octylacrylamide, maleic anhydride, maleic acid,

monoethyl maleate, diethyl maleate, monooctyl maleate, dioctyl

maleate; and their corresponding sodium, potassium, ammonium,

isopropylamine, triethylamine, monoethanolamine, and/or

triethanolamine salts; the resulting polymer having a minimum

number average molecular weight (in amu), 1,200

Acrylonitrile-butadiene copolymer conforming to 21 CFR 180.22,
9003-18-3

minimum average molecular weight (in amu), 1,000

Acrylonitrile-styrene-hydroxypropyl methacrylate copolymer,
None

minimum number average molecular weight (in amu), 447,000

α-alkyl (C₁₂-C₁₅)-ω-
68551-13-3

hydroxypoly(oxypropylene)poly(oxyethylene)copolymers (where the

poly(oxypropylene) content is 3-60 moles and the poly(oxyethylene)

content is 5-80 moles), the resulting ethoxylated propoxylated (C₁₂-C₁₅)

alcohols having a minimum molecular weight (in amu), 1,500

α-Alkyl-ω-hydroxypoly (oxypropylene) and/or poly (oxyethylene)
9035-85-2; 9038-29-3;

polymers where the alkyl chain contains a minimum of six carbons
9038-43-1; 9040-05-5;

and a minimum number average molecular weight (in amu) 1,100
25190-05-0; 25231-21-

4; 26636-39-5; 27252-

75-1; 37311-00-5;

37311-01-6; 37311-04-

9; 50861-66-0; 52232-

09-4; 59112-62-8;

62648-50-4; 63303-01-

5; 63658-45-7; 63793-

60-2; 64415-24-3;

64415-25-4; 64425-86-

1; 65104-72-5; 65150-

81-4; 67254-71-1;

67763-08-0; 68238-81-

3; 68238-82-4; 68409-

58-5; 68409-59-6;

68439-30-5; 68439-48-

5; 68439-53-2; 68526-

95-4; 68603-20-3;

68920-69-4; 68954-94-

9; 68991-48-0; 69227-

20-9; 70955-07-6;

71011-10-4; 72066-65-

0; 72108-90-8; 72484-

69-6; 73018-31-2;

74432-13-6; 74499-34-

6; 79771-03-2; 102782-

43-4; 103331-86-8;

103657-84-7; 103657-

85-8; 103819-03-0;

116810-32-3; 116810-

33-4; 120944-68-5;

121617-09-2; 126646-

02-4; 126950-62-7;

139626-71-4; 152231-

44-2; 154518-36-2;

157627-88-8; 157707-

41-0; 157707-43-2;

159653-49-3; 160901-

09-7; 160901-19-9;

160901-20-2; 161025-

21-4; 161025-22-5;

176022-76-7; 287935-

46-0; 288260-45-7;

303176-75-2; 954108-

36-2

Alkyl (C₁₂-C₂₀) methacrylate-methacrylic acid copolymer, minimum
None

molecular weight (in amu), 11,900

2H-Azepin-2-one, 1-ethenylhexahydro-, homopolymer
25189-83-7

1,3 Benzene dicarboxylic acid, 5-sulfo-, 1,3-dimethyl ester, sodium
212842-88-1

salt, polymer with 1,3-benzene dicarboxylic acid, 1,4-benzene

dicarboxylic acid, dimethyl 1,4-benzene dicarboxylate and 1,2-

ethanediol, minimum number average molecular weight (in amu),

2,580

3,5-Bis(6-isocyanatohexyl)-2H-1,3,5-oxadiazine-2,4,6-(3H,5H)-
87823-33-4

trione, polymer with diethylenetriamine, minimum number average

molecular weight (in amu), 1,000,000

Polymer of one or more diglycidyl ethers of bisphenol A, resorcinol,
None

glycerol, cyclohexanedimethanol, neopentyl glycol, and polyethylene

glycol with one or more of the following: Polyoxypropylene diamine,

polyoxypropylene triamine, N-aminoethyl-piperazine, trimethyl-1,6-

hexanediamine isophorone diamine, N,N-dimethyl-1,3-

diaminopropane, nadic methyl anhydride, 1,2-cyclohexane-

dicarboxylic anhydride and 1,2,3,6-tetrahydrophthalic anhydride,

minimum number average molecular weight (in amu), 400,000

Butadiene-styrene copolymer
None

1,4-Butanediol-methylenebis(4-phenylisocyanate)-
9018-04-6

poly(tetramethylene glycol) copolymer, minimum molecular weight

(in amu) 158,000

Butene, homopolymer
9003-29-6

2-butenedioic acid (2Z)-, monobutyl ester, polymer with
205193-99-3

methoxyethene, sodium salt, minimum number average molecular

weight (in amu), 18,200

2-Butenedioic acid (Z)-, polymer with ethenol and ethenyl acetate,
139871-83-3

sodium salt, minimum number average molecular weight (in amu),

75,000

Butyl acrylate-vinyl acetate-acrylic acid copolymer, minimum number
65405-40-5

average molecular weight (in amu), 18,000

Carbonic acid, diethyl ester, polymer with α-hydro-ω-
1147260-65-8

hydroxypoly[oxy(methyl-1,2-ethanediyl)] ether with 2-ethyl-2-

(hydroxymethyl)-1,3-propanediol (3:1), ester with α-[[[[5-

(carboxyamino)-1,3,3-trimethylcyclohexyl]methyl]amino]carbonyl]-ω-

methoxypoly(oxy-1,2-ethanediyl), minimum number average

molecular weight (in amu), 1,900

Castor oil, ethoxylated, dioleate, minimum number average
110531-96-9

molecular weight (in amu), 1260.

Castor oil, ethoxylated, oleate, minimum number average molecular
220037-02-5

weight (in amu), 1,600

Castor oil, polymer with adipic acid, linoleic acid, oleic acid and
1357486-09-9

ricinoleic acid, minimum number average molecular weight (in amu),

3,500

Castor oil, polyoxyethylated; the poly(oxyethylene) content averages
None

5-54 moles

Chlorinated polyethylene
64754-90-1

Cross-linked nylon-type polymer formed by the reaction of a mixture
None

of sebacoyl chloride and polymethylene polyphenylisocycanate with

a mixture of ethylenediamine and diethylenetriamine

Cross-linked polyurea-type encapsulating polymer
None

Dimethylpolysiloxane minimum number average molecular weight (in
63148-62-9

amu), 6,800

Dimethyl silicone polymer with silica, minimum number average
67762-90-7

molecular weight (in amu), 1,100,000

α-(o,p-Dinonylphenyl)-ω-hydroxypoly(oxyethylene) produced by
9014-93-1

condensation of 1 mole of dinonylphenol (nonyl group is a propylene

trimer isomer) with an average of 140-160 moles of ethylene oxide

Docosyl methacrylate-acrylic acid copolymer, or docosyl
None

methacrylate-octadecyl methacrylate-acrylic acid copolymer,

minimum number average molecular weight (in amu), 3,000

1,12-Dodecanediol dimethacrylate polymer, minimum molecular
None

weight (in amu), 100,000

α-(p-Dodecylphenyl)-ω-hydroxypoly(oxyethylene) produced by the
9014-92-0

condensation of 1 mole of dodecylphenol (dodecyl group is a
26401-47-8

propylene tetramer isomer) with an average of 30-70 moles of

ethylene oxide

1,2-Ethanediamine, N1-(2-aminoethyl)-, polymer with 2,4-
35297-61-1

diisocyanato-1-methylbenzene, minimum number average molecular

weight (in amu), one million

1,2-Ethanediamine, polymer with methyl oxirane and oxirane,
26316-40-5

minimum number average molecular weight (in amu), 1,100

Ethylene glycol dimethyacrylate-lauryl methacrylate copolymer,
None

minimum molecular weight (in amu), 100,000

Ethylene glycol dimethacrylate polymer, minimum molecular weight
None

(in amu), 100,000

Fatty acids, tall-oil, ethoxylated propoxylated, minimum number
67784-86-5

average molecular weight (in amu), 2,009

Formaldehyde, polymer with α-[bis(1-phenylethyl)phenyl]-ω-
157291-93-5

hydroxypoly(oxy-1,2-ethanediyl), number average molecular weight

(in amu), 1,803

Formaldehyde, polymer with 2-methyloxirane and 4-nonylphenol,
37523-33-4

minimum number average molecular weight (in amu), 4,000

Fumaric acid-isophthalic acid-styrene-ethylene/propylene glycol
None

copolymer, minimum average molecular weight (in amu), 1 × 10¹⁸

2,5-Furandione, polymer with ethenylbenzene, hydrolyzed, 3-
1062609-13-5

(dimethylamino)propyl imide, imide with polyethylene-polypropylene

glycol 2-aminopropyl me ether, 2,2′-(1,2-diazenediyl)bis[2-

methylbutanenitrile]-initiated, minimum number average molecular

weight (in amu), 5,816

2,5-Furandione, polymer with ethenylbenzene, reaction products
162568-32-3

with polyethylene-polypropylene glycol 2-aminopropyl Me ether;

minimum number average molecular weight (in amu), 14,000

Hexadecyl acrylate-acrylic acid copolymer, hexadecyl acrylate-butyl
None

acrylate-acrylic acid copolymer, or hexadecyl acrylate-dodecyl

acrylate-acrylic acid copolymer, minimum number average molecular

weight (in amu), 3,000

Hexamethyl disilizane, reaction product with silica, minimum number
68909-20-6

average molecular weight (in amu), 645,000

1,6-Hexanediol dimethyacrylate polymer, minimum molecular weight
None

(in amu), 100,000

α-Hydro-ω-hydroxy-poly(oxyethylene) C8 alkyl ether citrates,
330977-00-9

poly(oxyethylene) content is 4-12 moles, minimum number average

molecular weight (in amu) 1,300

α-Hydro-ω-hydroxy-poly(oxyethylene) C10-C16-alkyl ether citrates,
330985-58-5

poly(oxyethylene) content is 4-12 moles, minimum number average

molecular weight (in amu) 1,100

α-Hydro-ω-hydroxy-poly(oxyethylene) C16-C18-alkyl ether citrates,
330985-61-0

poly(oxyethylene) content is 4-12 moles, minimum number average

molecular weight (in amu) 1,300

α-Hydro-ω-hydroxypoly(oxyethylene), minimum number average
25322-68-3

molecular weight (in amu), 17,000

α-Hydro-ω-hydroxypoly(oxyethylene)poly (oxypropylene)
None

poly(oxyethylene) block copolymer; the minimum poly(oxypropylene)

content is 27 moles and the minimum molecular weight (in amu) is

1,900

α-Hydro-ω-hydroxypoly(oxypropylene); minimum molecular weight
None

(in amu) 2,000

12-Hydroxystearic acid-polyethylene glycol copolymer, minimum
70142-34-6

number average molecular weight (in amu), 3,690

Isodecyl alcohol ethoxylated (2-8 moles) polymer with chloromethyl
None

oxirane, minimum number average molecular weight (in amu) 2,500

Lauryl methacrylate-1,6-hexanediol dimethacrylate copolymer,
None

minimum molecular weight (in amu), 100,000

Maleic acid-butadiene copolymer
None

Maleic acid monobutyl ester-vinyl methyl ether copolymer, minimum
25119-68-0

average molecular weight (in amu), 52,000

Maleic acid monoethyl ester-vinyl methyl ether copolymer, minimum
25087-06-3

average molecular weight (in amu), 46,000

Maleic acid monoisopropyl ester-vinyl methyl ether copolymer,
31307-95-6

minimum average molecular weight (in amu), 49,000

Maleic anhydride-diisobutylene copolymer, sodium salt, minimum
37199-81-8

number average molecular weight (in amu) 5,0007-18,000

Maleic anhydride-methylstyrene copolymer sodium salt, minimum
60092-15-1

number average molecular weight (in amu), 15,000

Maleic anhydride-methyl vinyl ether, copolymer, average molecular
None

weight (in amu), 250,000

Methacrylic acid-methyl methacrylate-polyethylene glycol methyl
100934-04-1

ether methacrylate copolymer, minimum number averge molecular

weight (in amu), 3,700

Methacrylic acid-methyl methacrylate-polyethylene glycol
111740-36-4

monomethyl ether methacrylate graft copolymer, minimum number

average molecular weight (in amu), 1,800

Methacrylic copolymer, minimum number average molecular weight
63150-03-8

(in amu), 15,000

Methyl methacrylate-methacrylic acid-monomethoxypolyethylene
119724-54-8

glycol methacrylate copolymer,) minimum number average

molecular weight (in amu), 2,730

Methyl methacrylate-2-sulfoethyl methacrylate-
None

dimethylaminoethylmethacrylate-glycidyl methacrylate-styrene-2-

ethylhexyl acrylate graft copolymer, minimum average molecular

weight (in amu), 9,600

Methyl vinyl ether-maleic acid copolymer), minimum number
25153-40-6

average molecular weight (in amu), 75,000

Methyl vinyl ether-maleic acid copolymer, calcium sodium salt,
62386-95-2

minimum number average molecular weight (in amu), 900,000

Monophosphate ester of the block copolymer α-hydro-ω-
None

hydroxypoly(oxyethylene) poly(oxypropylene) poly(oxyethylene); the

poly(oxypropylene) content averages 37-41 moles, average

molecular weight (in amu), 8,000

α-(p-Nonylphenyl)-ω-hydroxypoly(oxyethylene) mixture of
None

dihydrogen phosphate and monohydrogen phosphate esters and the

corresponding ammonium, calcium, magnesium,

monoethanolamine, potassium, sodium, and zinc salts of the

phosphate esters; the nonyl group is a propylene trimer isomer and

the poly(oxyethylene) content averages 30 moles

α-(p-Nonylphenyl)-ω-hydroxypoly(oxyethylene) sulfate, and its
None

ammonium, calcium, magnesium, monoethanolamine, potassium,

sodium, and zinc salts; the nonyl group is a propylene trimer isomer

and the poly(oxyethylene) content averages 30-90 moles of ethylene

oxide

α-(p-Nonylphenyl-ω-hydroxypoly(oxypropylene) block polymer with
None

poly(oxyethylene); polyoxypropylene content of 10-60 moles;

polyoxyethylene content of 10-80 moles; molecular weight (in amu),

1,200-7,100.

α-(ρ-Nonylphenyl)poly(oxypropylene) block polymer with
37251-69-7

poly(oxyethylene); poly oxyethylene content 30 to 90 moles;

minimum number average molecular weight (in amu), 1,889

Octadecanoic Acid, 12-Hydroxy-, Homopolymer Ester with 2-
1373125-59-7

Methylloxirane Polymer with Oxirane monobutyl Ether, minimum

number average molecular weight (in amu), 4,500

Octadecanoic acid, 12-hydroxy-, homopolymer, octadecanoate
58128-22-6)

minimum number average molecular weight (in amu), 1,370

α-cis-9-Octadecenyl-ω-hydroxypoly(oxyethylene); the octadecenyl
None

group is derived from oleyl alcohol and the poly(oxyethylene) content

averages 20 moles

Octadecyl acrylate-acrylic acid copolymer, octadecyl acrylate-
None

dodecyl acrylate-acrylic acid copolymer, octadecyl methacrylate-

butyl acrylate-acrylic acid copolymer, octadecyl methacrylate-hexyl

acrylate-acrylic acid copolymer, octadecyl methacrylate-dodecyl

acrylate-acrylic acid copolymer, or octadecyl methacrylate-dodecyl

methacrylate-acrylic acid copolymer, minimum number average

molecular weight (in amu) 3,000

Oleic acid diester of α-hydro-ω-hydroxypoly(oxyethylene); the
None

poly(oxyethylene), average molecular weight (in amu), 2,300

2-oxepanone, homopolymer, minimum number average molecular
24980-41-4

weight (in amu) 52,000

Oxirane, decyl-, reaction products with polyethylene-polypropylene
903890-89-1

glycol ether with trimethylolpropane (3:1)

Oxirane, hexadecyl-, reaction products with polyethylene-
893427-80-0

polypropylene glycol ether with trimethylolpropane (3:1)

Oxirane, 2-methyl-, polymer with oxirane, dimethyl ether, minimum
61419-46-3

number average molecular weight (in amu), 2,800

Oxirane, methyl-, polymer with oxirane, ether with 2-ethyl-2-
903890-90-4

(hydroxymethyl)-1,3-propanediol (3:1), reaction products with

tetradecyloxirane

Oxirane, methyl-, polymer with oxirane, mono[2-(2-butoxyethoxy)
85637-75-8

ethyl] ether, minimum number average molecular weight (in amu),

2,500

Oxirane, methyl-, polymer with Oxirane, Monobutyl Ether
9038-95-3

Oxirane, 2-methyl-, polymer with oxirane, minimum number average
9003-11-6

molecular weight (in amu), 1,100

Oxirane, 2-methyl-, polymer with oxirane, mono [2-[2-(2-
926031-36-9

butoxymethylethoxy)methylethoxy]methylethyl] ether, minimum

number average molecular weight (in amu), 3,000

Polyamide polymer derived from sebacic acid, vegetable oil acids
None

with or without dimerization, terephthalic acid and/or

ethylenediamine

Polyethylene glycol-polyisobutenyl anhydride-tall oil fatty acid
68650-28-2

copolymer, minimum number average molecular weight (in amu),

2,960

Polyethylene, oxidized, minimum number average molecular weight
None

(in amu), 1,200

Polymers produced by the reaction of either 1,6-hexanediisocyanate;
1161844-26-3,

2,4,4-trimethyl-1,6-hexanediisocyanate; 5-isocyanato-1-
1161844-30-9,

(isocyanatomethyl)-fxsp0; 1,3,3fxsp0; -trimethylcyclohexane
1161844-43-4,

(isophoronediisocyanate); 4,4′-methylene-bis-1,1′-
1161844-51-4,

cyclohexanediisocyanate; 4,4′-methylene-bis-1,1′
1161844-53-6, 693252-

benzyldiisocyanate; or 1,3-bis-(2-isocyanatopropan-2-yl)benzene
31-2, 162993-60-4,

with polyethylene glycol and end-capped with one or a mixture of
630102-86-2

more than one of octanol, decanol, dodecanol, tetradecanol,

hexadecanol, octadecanol, and octadec-9-enol or polyethyleneglycol

ethers of octanol, decanol, dodecanol, tetradecanol, hexadecanol,

octadecanol, and octadec-9-enol, minimum number average

molecular weight (in amu), 20,000

Polymethylene polyphenylisocyanate, polymer with ethylene
None

diamine, diethylene triamine and sebacoyl chloride, cross-linked;

minimum number average molecular weight (in amu), 100,000

Polyoxyalkylated glycerol fatty acid esters; the mono-, di-, or
61791-23-9, 68201-46-

triglyceride mixtures of C₈through C₂₂, primarily C₈through C₁₈
7, 68440-49-3, 68458-

saturated and unsaturated, fatty acids containing up to 15% water by
88-8, 68606-12-2,

weight reacted with a minimum of three moles of either ethylene
68648-38-4, 70377-91-

oxide or propylene oxide; the resulting polyoxyalkylated glycerol
2, 70914-02-2, 72245-

ester polymer minimum number average molecular weight (in amu),
12-6, 72698-41-3,

1,500
180254-52-8, 248273-

72-5, 308063-50-5,

952722-33-7

Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, polymer with 1,1′-
39444-87-6

methylene-bis-[4-isocyanatocyclohexane], minimum number

average molecular weight (in amu), 1800

Polyoxyethylated primary amine (C₁₄-C₁₈); the fatty amine is derived
None

from an animal source and contains 3% water; the poly(oxyethylene)

content averages 20 moles

Polyoxyethylated sorbitol fatty acid esters; the polyoxyethylated
None

sorbitol solution containing 15% water is reacted with fatty acids

limited to C₁₂, C₁₄, C₁₆, and C₁₈, containing minor amounts of

associated fatty acids; the poly(oxyethylene) content averages 30

moles.

Polyoxyethylated sorbitol fatty acid esters; the sorbitol solution
None

containing up to 15% water is reacted with 20-50 moles of ethylene

oxide and aliphatic alkanoic and/or alkenoic fatty acids C₈through

C₂₂with minor amounts of associated fatty acids; the resulting

polyoxyethylene sorbitol ester having a minimum molecular weight

(in amu), 1,300

Poly(oxyethylene/oxypropylene) monoalkyl (C₆-C₁₀) ether sodium
102900-02-7

fumarate adduct, minimum number average molecular weight (in

amu), 1,900

Polyoxymethylene copolymer, minimum number average molecular
None

weight (in amu), 15,000

Poly(oxypropylene) block polymer with poly(oxyethylene), molecular
None

weight (in amu), 1,800-16,000

Poly(phenylhexylurea), cross-linked, minimum average molecular
None

weight (in amu), 36,000

Polypropylene
9003-07-0

Polystyrene, minimum number average molecular weight (in amu),
9003-53-6

50,000

Polytetrafluoroethylene
9002-84-0

Polyvinyl acetate, copolymer with maleic anhydride, partially
None

hydrolyzed, sodium salt, minimum number average molecular weight

(in amu), 53,000

Polyvinylpyrrolidone butylated polymer, minimum number average
26160-96-3

molecular weight (in amu), 9,500

Polyvinyl acetate, minimum molecular weight (in amu), 2,000
None

Polyvinyl acetate—polyvinyl alcohol copolymer, minimum number
25213-24-5

average molecular weight (in amu), 50,000

Polyvinyl alcohol
9002-89-5

Polyvinyl chloride
None

Polyvinyl chloride, minimum number average molecular weight (in
9002-86-2

amu), 29,000

Poly(vinylpyrrolidone), minimum number average molecular weight
9003-39-8

(in amu), 4,000

Poly(vinylpyrrolidone-1-eicosene), minimum average molecular
28211-18-9

weight (in amu), 3,000

Poly(vinylpyrrolidone-1-hexadecene), minimum average molecular
63231-81-2

weight (in amu), 4,700

1-propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propenyl)amino]-,
107568-12-7

monosodium salt, polymer with ethenol and ethenyl acetate,

minimum number average molecular weight (in amu) 50,000

2-Propene-1-sulfonic acid sodium salt, polymer with ethenol and
None

ethenyl acetate, number average molecular weight (in amu) 6,000-

12,000

2-propenoic acid, butyl ester, polymer with ethenylbenzene, methyl
27306-39-4

2-methyl-2-propenoate and 2-propenoic acid (in amu), 1900.

2-Propenoic acid, butyl ester, polymer with ethyl 2-propenoate and
33438-19-6

N-(hydroxymethyl)-2-propenamide, minimum number average

molecular weight (in amu), 30,000

2-Propenoic acid, 2-ethylhexyl ester, polymer with ethenylbenzene
25153-46-2

14,000 daltons

2-Propenoic acid, 2-ethylhexyl ester, polymer with ethenylbenzene
68240-06-2

and 2-methylpropyl 2-methyl-2-propenoate, minimum number

average molecular weight (in amu), 18,000

2-Propenoic acid, 2-hydroxyethyl ester, polymer with α-[4-
1007234-89-0

(ethenyloxy)butyl]-ω-hydroxypoly (oxy-1,2-ethanediyl), minimum

number average molecular weight (in amu), 17,000

[2-propenoic acid, 2-methyl-, C12-16-alkyl esters, telomers with 1-
950207-35-9

dodecanethiol, polyethylene-polypropylene glycol ether with

propylene glycol monomethacrylate (1:1), and styrene 2,2′-(1,2-

diazenediyl)bis[2-methylbutanenitrile]-initiated, minimum number

average molecular weight (in amu), 4,000

2-Propenoic acid, methyl ester, polymer with ethenyl acetate,
886993-11-9

hydrolyzed, sodium salts

2-Propenoic acid, 2-methyl-, 2-ethylhexyl ester, telomer with 1-
1283712-50-4

dodecanethiol, ethenylbenzene and 2-methyloxirane polymer with

oxirane monoether with 1,2-propanediol mono(2-methyl-2-

propenoate), hydrogen 2-sulfobutanedioate, sodium salt, 2, 2′-(1,2-

diazenediyl)bis[2-methylpropanenitrile]-initiated, minimum number

average molecular weight (in amu), 1,200

2-Propenoic acid, 2-methyl-, phenylmethyl ester, polymer with 2-
CASRN 1246766-57-3

propenoic acid and sodium 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-

1-propanesulfonate (1:1), peroxydisulfuric acid ([HO)S(O)2]202)

sodium salt (1:2)-initiated minimum number average molecular

weight >1,000 Daltons; maximum number average molecular weight

10,000 Daltons

2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate and
25036-16-2

ethenylbenzene, minimum number average molecular weight (in

amu), 17,000

2-Propenoic acid, 2-Methyl-, Polymer with Butyl 2-Propenoate,
153163-36-1

Methyl 2-Methyl-2-Propenoate, Methyl 2-Propenoate and 2-

Propenoic Acid, graft, Compound with 2-Amino-2-Methyl-1-Propanol

2-Propenoic Acid, 2-Methyl-, Polymer with Ethenylbenzene, 2-
146753-99-3

Ethylhexyl 2-Propenoate, 2-Hydroxyethyl 2-Propenoate, N-

(Hydroxymethyl)-2-Methyl-2-Propenamide and Methyl 2-Methyl-2-

Propenoate, Ammonium Salt

2-Propenoic acid, 2-methyl-, polymers with Bu acrylate, Et acrylate,
890051-63-5

Me methacrylate and polyethylene glycol methacrylate C_16-18-alkyl

ethers, minimum number average molecular weight (in amu), 13,000

2-Propenoic acid, 2-methyl-, telomer with 2-ethylhexyl 2-propenoate,
1260001-65-7

2-propanol and sodium 2-methyl-2-[(1-oxo-2-propen-1-yl) amino]-1-

propanesulfonate (1:1), sodium salt, minimum number average

molecular weight (in amu): 2,900

2-Propenoic acid, monoester with 1,2-propanediol, polymer with α-
955015-23-3

[4-(ethenyloxy) butyl]-ω-hydroxypoly (oxy-1,2-ethanediyl) and 2,5-

furandione, minimum number average molecular weight (in amu),

25,000

2-propenoic acid polymer, with 1,3-butadiene and ethenylbenzene,
25085-39-6

minimum number average molecular weight (in amu), 9400

2-Propenoic acid, polymer with ethenylbenzene and (1-
129811-24-1

methylethenyl) benzene, sodium salt, minimum number average

molecular weight (in amu), 2,800

2-Propenoic acid, polymer with α-[4-(ethenyloxy) butyl]-ω-
251479-97-7

hydroxypoly (oxy-1,2-ethanediyl) and 2,5-furandione, sodium salt,

minimum number average molecular weight (in amu), 25,000

2-Propenoic acid, polymer with α-[4-(ethenyloxy) butyl]-ω-
518026-64-7

hydroxypoly (oxy-1,2-ethanediyl) and 1,2-propanediol mono-2-

propenoate, potassium sodium salt, minimum number average

molecular weight (in amu), 16,000

2-Propenoic acid, polymer with α-[4-(ethenyloxy) butyl]-ω-
250591-84-5

hydroxypoly (oxy-1,2-ethanediyl), sodium salt, minimum number

average molecular weight (in amu), 24,000

2-Propenoic acid, polymer with 2-propenamide, sodium salt,
25085-02-3

minimum number average molecular weight (in amu), 18,000

2-Propenoic acid, sodium salt, polymer with 2-propenamide,
25987-30-8

minimum number average molecular weight (in amu), 18,000

2-Propenoic, 2-methyl-, polymers with ethyl acrylate and
888969-14-0

polyethylene glycol methylacrylate C_18-22alkyl ethers

2-Pyrrolidone, 1-ethenyl-, polymer with ethenol, minimum number
26008-54-8

average molecular weight (in amu), 23,000

Silane, dichloromethyl-reaction product with silica minimum number
68611-44-9

average molecular weight (in amu), 3,340,000

Silane, trimethoxy[3-(oxiranylmethoxy)propyl]-, hydrolysis products
68584-82-7

with silica, minimum number average molecular weight (in amu),

640,000

Silicic acid, sodium salt, reaction products with chlorotrimethylsilane
None

and iso-propyl alcohol, reaction with poly(oxypropylene)-

poly(oxyethylene) glycol, minimum number average molecular

weight (in amu), 75,000

Sodium polyflavinoidsulfonate, consisting chiefly of the copolymer of
None

catechin and leucocyanidin

Soybean oil, ethoxylated; the poly(oxyethylene) content averages 10
61791-23-9

moles or greater

Starch, oxidized, polymers with Bu acrylate, tert-Bu acrylate and
204142-80-3

styrene, minimum number average molecular weight (in amu),

10,000

Stearyl methacrylate-1,6-hexanediol dimethacrylate copolymer,
None

minimum molecular weight (in amu), 100,000

Styrene, copolymers with acrylic acid and/or methacrylic acid, with
None

none and/or one or more of the following monomers:

Acrylamidopropyl methyl sulfonic acid, methallyl sulfonic acid, 3-

sulfopropyl acrylate, 3-sulfopropyl methacrylate, hydroxypropyl

methacrylate, hydroxypropyl acrylate, hydroxyethyl methacrylate,

hydroxyethyl acrylate, and/or lauryl methacrylate; and its sodium,

potassium, ammonium, monoethanolamine, and triethanolamine

salts; the resulting polymer having a minimum number average

molecular weight (in amu), 1200

Styrene-ethylene-propylene block copolymer, minimum number
108388-87-0

average molecular weight (in amu), 125,000

Styrene, 2-ethylhexyl acrylate, butyl acrylate copolymer, minimum
30795-23-4

number average molecular weight (in amu), 4,200

Styrene-2-ethylhexyl acrylate-glycidyl methacrylate-2-acrylamido-2-
None

methylpropanesulfonic acid graft copolymer, minimum number

average molecular weight (in amu), 12,500

Styrene-maleic anhydride copolymer
None

Styrene-maleic anhydride copolymer, ester derivative
None

Tall oil, polymer with polyethylene glycol and succinic anhydride
1398573-80-2

monopolyisobutylene derivs., minimum number average molecular

weight (in amu), 1,200

Tetradecyl acrylate-acrylic acid copolymer, minimum number
None

average molecular weight (in amu), 3,000

Tetraethoxysilane, polymer with hexamethyldisiloxane, minimum
104133-09-7

number average molecular weight (in amu), 2,500

Tetraethoxysilane, polymer with hexamethyldisiloxane, minimum
104133-09-7

number average molecular weight (in amu), 6,500

α-[p-(1,1,3,3-Tetramethylbutyl)phenyl]-ω-hydroxypoly(oxyethylene)
9036-19-5

produced by the condensation of 1 mole of p-(1,1,3,3-
9002-93-1

tetramethylbutyl)phenol with a range of 30-70 moles of ethylene

oxide

α-[p-(1,1,3,3-Tetramethylbutyl)phenyl] poly(oxypropylene) block
None

polymer with poly(oxyethylene); the poly(oxypropylene) content

averages 25 moles, the poly(oxyethylene) content averages 40

moles, the molecular weight (in amu) averages 3,400

α-[2,4,6-Tris[1-(phenyl)ethyl]phenyl]-ω-hydroxy poly(oxyethylene)
None

poly(oxypropylene) copolymer, the poly(oxypropylene) content

averages 2-8 moles, the poly(oxyethylene) content averages 16-30

moles, average molecular weight (in amu), 1,500

Urea-formaldehyde copolymer, minimum average molecular weight
9011-05-6

(in amu), 30,000

Vinyl acetate-allyl acetate-monomethyl maleate copolymer, minimum
None

average molecular weight (in amu), 20,000

Vinyl acetate-ethylene copolymer, minimum number average
24937-78-8

molecular weight (in amu), 69,000

Vinyl acetate polymer with none and/or one or more of the following
None

monomers: Ethylene, propylene, N-methyl acrylamide, acrylamide,

monoethyl maleate, diethyl maleate, monooctyl maleate, dioctyl

maleate, maleic anhydride, maleic acid, octyl acrylate, butyl acrylate,

ethyl acrylate, methyl acrylate, acrylic acid, octyl methacrylate, butyl

methacrylate, ethyl methacrylate, methyl methacrylate, methacrylic

acid, carboxyethyl acrylate, and diallyl phthalate; and their

corresponding sodium, potassium, ammonium, isopropylamine,

triethylamine, monoethanolamine and/or triethanolamine salts; the

resulting polymer having a minimum number average molecular

weight (in amu), 1,200

Vinyl acetate-vinyl alcohol-alkyl lactone copolymer, minimum
None

number average molecular weight (in amu), 40,000; minimum

viscosity of 18 centipoise

Vinyl alcohol-disodium itaconate copolymer, minimum average
None

molecular weight (in amu), 50,290

Vinyl alcohol-vinyl acetate copolymer, benzaldehyde-o-sodium
None

sulfonate condensate, minimum number average molecular weight

(in amu), 20,000

Vinyl alcohol-vinyl acetate-monomethyl maleate, sodium salt-maleic
None

acid, disodium salt-γ-butyrolactone acetic acid, sodium salt

copolymer, minimum number average molecular weight (in amu),

20,000

Vinyl chloride-vinyl acetate copolymers
None

Vinyl pyrrolidone-acrylic acid copolymer, minimum number average
28062-44-4

molecular weight (in amu), 6,000

Vinyl pyrrolidone-dimethylaminoethylmethacrylate copolymer,
30581-59-0

minimum number average molecular weight (in amu), 20,000

Vinyl pyrrolidone-styrene copolymer
25086-29-7

In an embodiment, a silica precursor material to make the copper/silica nanocomposite can be made by mixing a silane compound (e.g., alkyl silane, tetraethoxysilane (TEOS), tetramethoxysilane, sodium silicate, or a silane precursor that can produce silicic acid or silicic acid like intermediates and a combination of these silane compounds) with a copper precursor compound (e.g. copper hydroxide and the like)), in an acidic medium (e.g., acidic water). In an embodiment, the pH can be adjusted to about 1.0 to 3.5 using a mineral acid such as nitric acid or hydrochloric acid. In an embodiment, the weight ratio of the silica precursor material to the copper precursor compound can be about 0.1:1 to 3:1. After mixing for a period of time (e.g., about 30 minutes to a few hours or about 12 to 36 hours), a mixture including silica nanoparticles with the copper nanoparticles can be formed. Subsequently, the medium can be brought to a pH of about 7 and held for a time period (e.g., a few hours to a day) to form a silica nanoparticle gel, where the silica nanoparticles are interconnected. In an embodiment, the copper nanoparticles can be part of the interconnection of the silica nanoparticles and/or dispersed within the matrix, while copper ions can be dispersed within the matrix as well. Next a polymer can be added to the mixture having an acidic pH. The mixture is stirred for about 12 to 36 hours. Subsequently, the pH is raised to about 4 using a base to form the composition. This process can be performed using a single reaction vessel or can use multiple reaction vessels.

In an embodiment, after the composition is disposed on the surface, the structure may have an antimicrobial characteristic that is capable of killing a substantial portion of the microorganisms (e.g., bacteria such as E. coli, B. subtilis and S. aureus) on the surface of the structure and/or inhibits or substantially inhibits the growth of the microorganisms on the surface of the structure. The phrase “killing a substantial portion” includes killing at least about 70%, at least about 80%, at least about 90%, at least about 95%, or at least about 99% of the microorganism (e.g., bacteria) on the surface that the composition is disposed on, relative to structure that does not have the composition disposed thereon. The phrase “substantially inhibits the growth” includes reducing the growth of the microorganism (e.g., bacteria) by at least about 70%, at least about 80%, at least about 90%, at least about 95%, or at least about 99% of the microorganisms on the surface that the composition is disposed on, relative to a structure that does not have the composition disposed thereon.

As mentioned above, embodiments of the present disclosure are effective for the treatment of diseases affecting plants such as citrus plants and trees. In an embodiment, the composition can function as an antibacterial and/or antifungal, specifically, treating, substantially treating, preventing or substantially preventing, plant diseases such as citrus greening (HLB) and citrus canker diseases. The copper can be released from the composition so that it can act as an antibacterial and/or antifungal for a period of time (e.g., from application to days to months). The design of the composition facilitates uniform plant surface coverage or substantially uniform plant surface coverage. In an embodiment, the composition that is applied to plants can have a superior adherence property in various types of exposure to atmospheric conditions such as rain, wind, snow, and sunlight, such that it is not substantially removed over the time frame of the release of the copper. In an embodiment, the composition has a reduced phytotoxic effect or is non-phytotoxic to plants and reduced environmental stress due to minimal Cu content.

Embodiments of the present disclosure can applied on the time frames consistent with the release of the copper, and these time frames can include from the first day of application to about a week, about a month, about two months, about three months, about four months, about five months, about six months, about seven month, or about eight months.

EXAMPLES
Example
Copper Silica Polymer Nanocomposite:
Materials and Methodology:
Materials:

Copper Hydroxide (65% Metallic Cu)—Supplied by Gowan Company (GWN 10202)

Copper Hydroxide (61% Metallic Cu)—Supplied by Gowan Company (GWN 10316)

Hydrochloric Acid (conc HCL)—Fisher Scientific-Technical Grade CAS#7647-01-0

Sodium Hydroxide (1M & 4M NaOH)—Amresco ACS Grade CAS#1310-73-2

Tetraethylorthosilicate (TEOS)—Gelest Inc—CAS#78-10-4

Polyacrylamide (PAAm)(50% wt)—Aldrich—Catalog#434949, MW Avg 10,000, CAS#9003-05-8

Polyvinylpyrrolidone (PVP) (40 & 50% w/w)—Acros Organics—MW 8000, CAS #9003-39-8

Ethanol (ETOH) (95%)(190 Proof)—Decon Laboratories Inc, Ethyl Alcohol CAS#64-17-5

Deionized H₂O—Barnstead Nanopure Diamond

Methodology:
SG 0001 (GWN 10227)

2.895 g of Cu(OH)₂(65% Metallic Cu) was added to 15 mL of EtOH along with 40 mL of deionized H₂O. This mixture was set to stir while slowly adding 6 mL of conc. HCL. An additional 303.8 mL of DI H₂O was added and left to stir for 30 mins to ensure all the Cu(OH) 2 was completely dissolved. After ensuring the Cu(OH) 2 was completely dissolved, 2.7 mL of TEOS was added dropwise and left to stir for 16-24 hrs. PAAm was then measured out and 112.5 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, 5 mL of 1M NaOH was used to raise the pH to 4.05. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=2.895 g, 65% Metallic Cu=1.88175 g,

(1.88175/485.4 ml)×1000=3.877 g/L Cu Specific Gravity=1.0222

SG0005 (GWN 10308)

2.775 g of Cu(OH) 2 (65% Metallic Cu) was added to 15 mL of EtOH along with 40 mL of deionized H₂O. This mixture was set to stir while slowly adding 6 mL of conc. HCL. An additional 294.5 mL of DI H₂O was added and left to stir for 30 mins to ensure all the Cu(OH)₂was completely dissolved. After ensuring the Cu(OH) 2 was completely dissolved, 2.7 mL of TEOS was added dropwise and left to stir for 16-24 hrs. PAAm was then measured out and 82.5 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, 17.8 mL of 1M NaOH was used to raise the pH to 4.08. The mixture was left to stir for 6-12 hrs before use.

Cu(OH) 2=2.775 g, 65% Metallic Cu=1.80375 g,

(1.80375/458.5 ml)×1000=3.934 g/L Cu Specific Gravity=1.0208

SG0015 (GWN 10309)

2.85 g of Cu (OH)₂(65% Metallic Cu) was added to 15 mL of EtOH along with 40 mL of deionized H₂O. This mixture was set to stir while slowly adding 6 mL of conc. HCL. An additional 291 mL of DI H₂O was added and left to stir for 30 mins to ensure all the Cu(OH)₂was completely dissolved. After ensuring the Cu(OH)₂was completely dissolved, 2.7 mL of TEOS was added dropwise and left to stir for 16-24 hrs. PVP (40% w/w) was then measured out and 97.5 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, 18 mL of 1M NaOH was used to raise the pH to 4.2. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=2.85 g, 65% Metallic Cu=1.8525 g,

(1.8525/470.2 ml)×1000=3.937 g/L Cu Specific Gravity=1.0086

SG0017 (GWN 10310)

2.85 g of Cu (OH) 2 (65% Metallic Cu) was added to 15 mL of EtOH along with 40 mL of deionized H₂O. This mixture was set to stir while slowly adding 6 mL of conc. HCL. An additional 292.6 mL of DI H₂O was added and left to stir for 30 mins to ensure all the Cu (OH) 2 was completely dissolved. After ensuring the Cu (OH) 2 was completely dissolved, 2.7 mL of TEOS was added dropwise and left to stir for 16-24 hrs. PAAm was then measured out and 90 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, 16.8 mL of 1M NaOH was used to raise the pH to 4.08. The mixture was left to stir for 6-12 hrs before use.

Cu (OH) 2=2.85 g, 65% Metallic Cu=1.8525 g,

(1.8525/463.1 ml)×1000=4 g/L Cu Specific Gravity=1.0271

SG0018 (GWN 10311)

2.895 g of Cu(OH)₂(65% Metallic Cu) was added to 15 mL of EtOH along with 40 mL of deionized H₂O. This mixture was set to stir while slowly adding 6 mL of conc. HCL. An additional 296 mL of DI H₂O was added and left to stir for 30 mins to ensure all the Cu(OH)₂was completely dissolved. After ensuring the Cu(OH)₂was completely dissolved, 2.7 mL of TEOS was added dropwise and left to stir for 16-24 hrs. PVP (40% w/w) was then measured out and 135 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, 17 mL of 1M NaOH was used to raise the pH to 4.2. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=2.895 g, 65% Metallic Cu=1.88175 g,
(1.88175/511.7)×1000=3.677 g/L Cu Specific Gravity=1.0130
SG0020 (GWN 10327)

10.416 g of Cu(OH)₂(65% Metallic Cu) was added to 15 mL of EtOH along with 73 mL of deionized H₂O. This mixture was set to stir while slowly adding 18 mL of conc. HCL. After ensuring the Cu(OH)₂was completely dissolved, 9.45 mL of TEOS was added dropwise and left to stir for 6-12 hrs. PAAm was then measured out and 393.75 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, 12 mL of 1M NaOH was used to raise the pH to 3.8. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=10.416 g, 65% Metallic Cu=6.7704 g,

(6.7704/521.2 ml)×1000=12.99 g/L Cu Specific Gravity=1.1541

SG0021 (GWN 10328)

5.356 g of Cu(OH)₂(65% Metallic Cu) was added to 15 mL of EtOH along with 34.6 mL of deionized H₂O. This mixture was set to stir while slowly adding 12 mL of conc. HCL. After ensuring the Cu(OH)₂was completely dissolved, 4.99 mL of TEOS was added dropwise and left to stir for 6-12 hrs. PAAm was then measured out and 207.68 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, 36 mL of 1M NaOH was used to raise the pH to 3.75. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=5.356 g, 65% Metallic Cu=3.4814 g,
(3.4814/310.27)×1000=11.22 g/L Cu Specific Gravity=1.1445
SG0022 (GWN 10332)

12.92 g of Cu(OH)₂(61% Metallic Cu) was added to 15 mL of EtOH along with 22 mL of conc. HCL slowly. After ensuring the Cu(OH)₂was completely dissolved, 11.1 mL of TEOS was added dropwise and left to stir for 6-12 hrs. PAAm was then measured out and 300 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, 71.78 mL of 1M NaOH was used to raise the pH to 4.33. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=12.92 g, 61% Metallic Cu=7.8812 g,
(7.8812/419.88)×1000=18.77 g/L Cu Specific Gravity=1.154
SG0022M

75 mL of SG0022 (GWN 10332) (pH 4.33) was raised to pH 8.67 using 34 mL of 1M NaOH. The new Cu content was determined to be 12.92 g/L. The mixture was left to stir for 6-12 hrs before use.

Specific Gravity=1.091
SG0023

4.5 g of Cu(OH)₂(61% Metallic Cu) was added to 10 mL of EtOH along with 10 mL of conc. HCL slowly. After ensuring the Cu(OH)₂was completely dissolved, 3.7 mL of TEOS was added dropwise and left to stir for 6 hrs. PAAm was then measured out and 100 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, ˜27 mL of 4M NaOH was used to raise the pH to 8.82. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=4.5 g, 61% Metallic Cu=2.745 g,

(2.745/151 ml)×1000=18.18 g/L Cu Specific Gravity=1.145

SG0024

4.5 g of Cu(OH)₂(61% Metallic Cu) was added to 14 mL of EtOH along with 8 mL of conc. HCL slowly. After ensuring the Cu(OH)₂was completely dissolved, 3.7 mL of TEOS was added dropwise and left to stir for 6 hrs. PVP (50% w/w) was then measured out and 100 mL was added to the stirring mixture and left for 16-24 hrs. At completion of stirring, ˜19.4 mL of 4M NaOH was used to raise the pH to 8.38. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=4.5 g, 61% Metallic Cu=2.745 g,
(2.745/145.1)×1000=18.92 g/L Cu Specific Gravity=1.094
Synthesis of SG0025 and SG0026

Copper Hydroxide, Cu(OH)₂, (61% Metallic Cu)—Supplied by Gowan Company (GWN 10316)

Hydrochloric Acid (conc HCL)—Fisher Scientific-Technical Grade CAS#7647-01-0

Sodium Hydroxide (6M NaOH)—Fisher Scientific CAS#1310-73-2

Tetraethylorthosilicate (TEOS)—Gelest Inc—CAS#78-10-4

Polyacrylamide (PAAm)(50% wt)—CarboMer, Inc. Cat#600-200, MW Avg 10,000, CAS#9003-05-8

Polyvinylpyrrolidone (PVP) (50% w/w)—Acros Organics—MW 8000, CAS #9003-39-8

Ethanol (ETOH) (95%)(190 Proof)—Decon Laboratories Inc, Ethyl Alcohol CAS#64-17-5

Deionized H₂O—Barnstead Nanopure Diamond

1) Code: SG 0025
Cu Source=Copper Hydroxide
Inactive Ingredient=Polyacrylamide (PAAm)
Metallic Cu Content=35.3 g/L
Specific Gravity=1.148
2) Code: SG 0026
Cu Source=Copper Hydroxide
Inactive Ingredient=Polyvinylpyrrolidone (PVP)
Metallic Cu Content=36.09 g/L
Specific Gravity=1.101

Synthesis of ˜500 mL of material

SG0025

30 g of Cu(OH)₂(61% Metallic Cu) was added to 40 mL of EtOH and 41 mL of H₂O along with 50 mL of conc. HCL slowly. After ensuring the Cu(OH)₂was completely dissolved (˜1 hr), 23 mL of TEOS was added slowly and left to stir for 4-6 hrs. PAAm was then measured out and 250 mL was added to the stirring mixture and left for 16-20 hrs. At completion of stirring, ˜105 mL of 4M NaOH was used to raise the pH to ˜7-8. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=30 g, 61% Metallic Cu=18.3 g,

Volume of Cu(OH)₂added, Density=3.368 g/cm³, D=M/V, therefore V=8.91 mL

Total Volume=517.9 mL

(18.3/517.9 ml)×1000=35.3 g/L Cu Specific Gravity=1.148

SG0026

30 g of Cu(OH)₂(61% Metallic Cu) was added to 40 mL of EtOH and 20 mL of H₂O along with 50 mL of conc. HCL slowly. After ensuring the Cu(OH)₂was completely dissolved (˜1 hr), 23 mL of TEOS was added slowly and left to stir for 4-6 hrs. PVP was then measured out and 250 mL was added to the stirring mixture and left for 16-20 hrs. At completion of stirring, ˜115 mL of 4M NaOH was used to raise the pH to ˜7-8. The mixture was left to stir for 6-12 hrs before use.

Cu(OH)₂=30 g, 61% Metallic Cu=18.3 g,

Volume of Cu(OH)₂added, Density=3.368 g/cm³, D=M/V, therefore V=8.91 mL

Total Volume=507 mL

(18.3/507 ml)×1000=36.09 g/L Cu Specific Gravity=1.101

Alternative SG0025-S Synthesis Protocol
Chemicals/Solvents

- 1. Gowan Copper Hydroxide, Cu(OH)₂, (60.9% Metallic Cu)—GWN 10316
- 2. Hydrochloric Acid (Conc. HCl)—Fisher Scientific-Technical Grade CAS#7647-01-0
- 3. Sodium Hydroxide (NaOH)—Fisher Scientific CAS#1310-73-2
- 4. Sodium Silicate (37%)—Fisher Scientific (Cat. #525566A; CAS#1344-09-8)
- 5. Polyacrylamide (PAAm; 50% w/w)—CarboMer, Inc. Cat#6-00200, MW Avg 10,000, CAS#9003-05-8
- 6. Deionized (DI) water—Barnstead Nanopure Diamond purifier

Synthesis of SG0025-S

Preparation of SG0025-S formulation was carried out in a 250 mL glass conical flask at room temperature and under continuous magnetic stirring (200 rpm) conditions.

- Add 8.0 g of Cu(OH)₂to 25 mL DI water and begin mixing.
- Then pour slowly 14 mL Conc. HCl into the solvent mixture to fully dissolve Cu (OH)₂.
- In a separate flask, add 6 mL of sodium silicate to 60 mL of polyacrylamide solution and stir vigorously.
- Stir both flasks for 25 mins.
- Add the polyacrylamide-sodium silicate mixture to the dissolved Cu(OH)₂and stir for an additional 30 mins.
- Then add 30 mL of 4M NaOH to raise the pH to −8.
- Stir for at least 2 hrs to ensure proper mixing and pH stabilization.
  
  Cu(OH)₂density=3.368 g/mol, therefore 8 g has a volume of 2.375 cm³; Total Volume=137.375 mL; Metallic Cu content 35.5 g/L Cu Specific Gravity=1.155

Table 1 is a summary of the Nanoformulation Compositions.

TEOS or
PVP

Metallic
Sodium
(40/50%
PAAm

Cu
Silicate
wt)
(50% wt)

Specific

Formulation Code
(g/L)
(mL)
(mL)
(mL)
pH
Gravity

SG0001
3.877
2.7
NA
112.5
4.05
1.0222

SG0005
3.934
2.7
NA
82.5
4.08
1.0208

SG0015
3.937
2.7
97.5
NA
4.2
1.0086

SG0017
4.0
2.7
NA
90
4.08
1.0271

SG0018
3.677
2.7
135
NA
4.2
1.0130

SG0020
12.99
9.45
NA
393.75
3.8
1.1541

SG0021
11.22
4.99
NA
207.68
3.75
1.1445

SG0022
18.77
11.1
NA
300
4.33
1.1540

SG0022M
12.92
11.1
NA
300
8.67
1.091

SG0023
18.18
3.7
NA
100
8.82
1.145

SG0024
18.92
3.7
100
NA
8.38
1.094

SG0025/SG0025-S
35.3/35.5
23 or 6
NA
250 or 60
8.5
1.148/1.155

SG0026
36.09
23
250
NA
8.6
1.101

Copper Silica Polymer Nanocomposite:
Characterization:

Scanning Electron Microscopy (SEM) and High-Resolution Transmission Electron Microscopy (HRTEM) was conducted to observe the morphology, crystallinity and confirm the elemental composition of the 2 nanoformulations (SG0023 and SG0024). SEM was conducted on a Zeiss Ultra-55 FEG SEM using mica wafers. The TEM was conducted on a FEI Tecnai F30 using carbon filmed gold grids.

In the SG0023 formulation, the elemental composition was confirmed using Energy Dispersive Spectroscopy (EDS) while doing SEM and HRTEM. The EDS confirmed the presence of our sample by identifying the Cu and Si in the material (FIGS. 2, 4, and 6). SEM images showed spherical clusters within the larger silica matrix, with aggregates ranging from 50-600 nm (FIGS. 1, 3, and 5). HRTEM exhibited a well dispersed material with areas of light and dark contrast of electron rich material (FIGS. 7 and 9). The crystallinity of the Cu materials were confirmed using Selected Area Electron Diffraction (SAED) (FIG. 8). Crystallites of Cu were clearly visible at high magnification. Determination of the lattice revealed spacing of 2.76 Å, 2.27 Å, 3.03 Å, 1.78 Å and 2.54 Å. These values correspond with CuO, CuO, Cu₂O, Cu and CuO respectively (FIGS. 10 and 11).

In the SG0024 formulation, the elemental composition was confirmed using Energy Dispersive Spectroscopy (EDS) while doing SEM and HRTEM. The EDS confirmed the presence of our sample by identifying the Cu and Si in the material (FIGS. 12, 19, and 21). SEM images showed spherical clusters within the larger silica matrix, with aggregates ranging from 50-300 nm (FIGS. 18 and 20). HRTEM exhibited a well dispersed material with areas of light and dark contrast of electron rich material (FIGS. 13 and 14). The crystallinity of the Cu materials were confirmed using Selected Area Electron Diffraction (SAED) (FIG. 15). Crystallites of Cu were clearly visible at high magnification. Determination of the lattice revealed spacing of 2.75 Å, 2.45 Å and 2.26 Å. These values correspond with CuO, Cu₂O and CuO respectively (FIGS. 16 and 17).

In the SG0025 formulation, the elemental composition was confirmed using Energy Dispersive Spectroscopy (EDS) while doing HRTEM. The EDS confirmed the presence of our sample by identifying the Cu and Si in the material (FIG. 29). HRTEM exhibited a well dispersed material with areas of light and dark contrast of electron rich material (FIGS. 30 and 31). The crystallinity of the Cu materials were confirmed using Selected Area Electron Diffraction (SAED) (FIG. 32). Crystallites of Cu were clearly visible at high magnification. Determination of the lattice revealed spacing of 2.48 Å, 2.48 Å, 1.44 Å and 1.87 Å which corresponds to Cu₂O, metallic Cu, Cu(OH)₂and CuO respectively.

In the SG0026 formulation, the elemental composition was confirmed using Energy Dispersive Spectroscopy (EDS) while doing HRTEM. The EDS confirmed the presence of our sample by identifying the Cu and Si in the material (FIG. 33). HRTEM exhibited a well dispersed material with areas of light and dark contrast of electron rich material (FIGS. 34 and 35). The crystallinity of the Cu materials were confirmed using Selected Area Electron Diffraction (SAED) (FIG. 36). Crystallites of Cu were clearly visible at high magnification. Determination of the lattice revealed spacing of as 2.48 Å, 2.11 Å, 1.44 Å, 1.95 Å, 2.79 Å and 1.87 Å which corresponds to Cu₂O, metallic Cu, Cu(OH)₂and CuO respectively.

Phytotoxicity Studies:

Phytotoxicity studies were conducted to observe plant injury on exposure to our nanoformulations. Studies were conducted on Vinca sp obtained from the local Home Depot and kept in a mini-greenhouse under conditions ≥80 F temperature and ≥40% humidity. Plants were obtained and allowed to acclimatize for 24 hrs before formula application. Nanoformulations were applied at specific Cu concentrations between 6 and 8 am before temperatures rose too high. Plants were observed for tissue damage at 24, 48 and 72 hr time points.

It was seen that SG0001, SG0005, SG0015, SG0017, SG0018, SG0020, SG0021 and SG0022 (FIGS. 22 and 23) caused moderate to high levels of plant tissue damage. SG0022M, SG0023, SG0024, SG0025, SG0026 and Kocide 3000 (FIGS. 22, 24, 37 and 38) exhibited no plant tissue damage at any Cu concentrations after 72 hrs. The reason for no toxicity was due to higher pHs in SG0022M, SG0023, SG0024 and Kocide 3000. Higher pHs lead to oxidation of Cu ions into less soluble Cu oxide and hydroxide.

Antimicrobial Studies:

Antimicrobial studies were conducted to ascertain the effectiveness of synthesized nanoformulations in comparison to the Kocide 3000 control. Studies conducted were growth inhibition assays using Muller Hinton 2 (MH2) broth and determination of the Minimum Inhibitory Concentration (MIC) following the guidelines of the Clinical and Laboratory Standards Institute (CLSI). Studies were conducted against gram negative E. coli sp.

Growth inhibition studies showed reduced bacterial growth as Cu concentration increased. Results indicated improved antimicrobial efficacy in Cu nanoformulations in relation to the Kocide 3000 control (FIGS. 26, 27, 28, and 39). The MIC of Cu nanoformulations was found to be 437.5 μg/mL for SG0001, SG0005, SG0015, SG0017 and SG0018. The MIC for SG0020, SG0021, SG0022, SG0022M, SG0023, and SG0024 was 500 μg/mL while Kocide 3000 had a value of 1000 μg/mL (FIG. 25). This reinforces the higher antimicrobial efficacy of our Cu nanoformulations.

It should be noted that ratios, concentrations, amounts, and other numerical data may be expressed herein in a range format. It is to be understood that such a range format is used for convenience and brevity, and thus, should be interpreted in a flexible manner to include not only the numerical values explicitly recited as the limits of the range, but also to include all the individual numerical values or sub-ranges encompassed within that range as if each numerical value and sub-range is explicitly recited. To illustrate, a concentration range of “about 0.1% to about 5%” should be interpreted to include not only the explicitly recited concentration of about 0.1 wt % to about 5 wt %, but also include individual concentrations (e.g., 1%, 2%, 3%, and 4%) and the sub-ranges (e.g., 0.5%, 1.1%, 2.2%, 3.3%, and 4.4%) within the indicated range. In an embodiment, the term “about” can include traditional rounding according to measurement techniques and the numerical value. In addition, the phrase “about ‘x’ to ‘y’” includes “about ‘x’ to about ‘y’”.

Many variations and modifications may be made to the above-described embodiments. All such modifications and variations are intended to be included herein within the scope of this disclosure and protected by the following claims.

	Number	Date	Country
Parent	15306907	Oct 2016	US
Child	15728196		US

	Number	Date	Country
Parent	14049732	Oct 2013	US
Child	15306907		US

COMPOSITIONS, METHODS OF MAKING A COMPOSITION, AND METHODS OF USE

Information

Publication Number

Date Filed

Date Published

Inventors

Original Assignees

CPC

International Classifications

Abstract

Description

Claims

CLAIM OF PRIORITY TO RELATED APPLICATION

Provisional Applications (1)

Continuations (1)

Continuation in Parts (1)